FDA Recalls Over 140,000 Bottles of Atorvastatin Cholesterol Medication
A large recall of atorvastatin, a widely used cholesterol-lowering drug, was issued due to manufacturing defects that affected drug dissolution, potentially reducing its effectiveness and increasing cardiovascular risk. Patients should check if their medication is affected and consult their healthcare provider before stopping or switching drugs. The recall highlights ongoing concerns about overseas manufacturing oversight and the need for vigilant consumer awareness.
